The largest database of trusted experimental protocols

10 protocols using human igg fc fragment

1

Metabolic Profiling of Activated T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Twelve-well non-tissue culture-treated plates (Corning #351143) were coated at 4 °C overnight with 1 µg/mL anti-CD3 antibody (BD biosciences 555329) and 1.5 µM human IgG Fc fragment (Jackson Immunoresearch #009-000-008) or 1.5 µM recombinant human Fc-tagged PD-L1 (rhPD-L1.Fc) (Sino Biological #10084-H02H) in 1.2 mL PBS per well. The plate was washed twice with 2 mL PBS and blocked for 1 h at room temperature with 1.5 mL human serum albumin 2.5% in phosphate-buffered solution (PBS), followed by two more washes with PBS. T-cells previously expanded for 7 days were isolated by immunomagnetic negative enrichment kit (ThermoFisher #11344D) and seeded in triplicate wells at 8.4 × 105cells in 1.2 mL glucose-free RPMI (ThermoFisher #11879020) supplemented with 10 mM [U-13C] glucose (Cambridge Isotope Laboratories #CLM-1396-PK), 10% dialyzed fetal calf serum, 1% SPF, and 1 µg/mL anti-CD28 antibody (BD biosciences #555725). For 72-h treatments, the treatment medium was refreshed 24 h prior to harvest.
+ Open protocol
+ Expand
2

Homo- and Heterodimerizing Agents Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Homo- and heterodimerizing agents AP20187 (Clackson et al., 1998 (link)), AP1887 (Yang et al., 2003 (link)), and AP21967 were obtained from Ariad Pharmaceuticals. Before stimulation, dimerizers were diluted in starving medium used for stimulation to the concentration indicated in the figures. Human IgG Fc fragment (Jackson ImmunoResearch Laboratories, Inc.), mouse ephrinB2-Fc, human ephrinB3-Fc, and human ephrinA5-Fc fusion proteins (R&D Systems) were used for stimulations. For preclustering Fc fragment and ephrin–Fc, fusion proteins were incubated with goat anti–human Fc at a ratio of 5:1 for 30 min at RT.
+ Open protocol
+ Expand
3

Oligomerization of Ephrin-Fc Fusion Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ephrin-A1, ephrin-A5, and ephrin-B2 fused to a human IgG-Fc fragment were purchased from Sigma-Aldrich (Tokyo, Japan; Product #E9902, #E0528, and #E0778, respectively). Before application to the cells, 5 μg of these ephrin-Fc compounds were oligomerized by mixing with 12 μg rabbit anti-human IgG-Fc (Jackson ImmunoResearch Laboratories, West Grove, PA, USA; Code #309-001-008) in 0.1 mL PBS at 4°C for at least 1 h. As a control for these ephrin preparations, a human IgG-Fc fragment (Jackson ImmunoResearch Laboratories; Code #009-000-008) was applied after oligomerization. The final concentration of oligomerized ephrins and IgG-Fc used for each study was 0.5 μg/mL. Human recombinant GH (Sigma-Aldrich; Product #S4776) was used at a final concentration of 0.5 μg/mL.
+ Open protocol
+ Expand
4

In vivo Thrombopoietin Signaling Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in vivo stimulation of Thpo signaling, recombinant human Thpo (PEG-rHuMGDF; Kabaya et al., 1996 (link); donated by Kyowa Hakko Kirin Co., Ltd.) was administered. Mice were treated with either 100 µg/kg (i.v.) of PEG-rHuMGDF or human IgG Fc fragment (Jackson ImmunoResearch Laboratories, Inc.). For rescue experiments, Clec2MkΔ/Δ mice were treated for four consecutive days.
+ Open protocol
+ Expand
5

VEGF, TSP1, and IgG Fc Fragment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
VEGF (human, recombinant) was from R&D Systems Inc. (Minneapolis, MN). Native human TSP1 was from Athens Research & Technology Inc. (Athens, GA). Human IgG, Fc fragment was purchased from Jackson ImmunoResearch Laboratories Inc. (West Grove, PA).
+ Open protocol
+ Expand
6

Activation of EphB2 Receptor in Enteric Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
To activate EphB2 receptor in mixed enteric cultures or colonic tissues, we used ephrinB2-Fc chimera (R&D Systems), preclustered with human IgG(Fc) fragment (Jackson ImmunoResearch Laboratories) before the application. To precluster, ephrin-B2-Fc, which connects mouse EphB2 to the Fc portion of the human IgG1 via a polypeptide linker, was mixed with anti-human Fc antibody (1:2) and incubated on ice for 30 min at room temperature. Eleven DIV primary cultures of ENS were stimulated for indicated times with clustered ephrinB2 at a concentration of 0.5 μg/ml. The human IgG(Fc) fragment was subjected to the same treatment and used as control. Cultures were then fixed or not for biochemical analysis or used for electrophysiological recordings.
+ Open protocol
+ Expand
7

Antibody Validation and Ligand Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies used were as follows: anti-Gulp1 (HPA020587; rabbit polyclonal; Sigma-Aldrich), anti-GFP (JL-8; mouse monoclonal; Clontech), anti-C-Myc (SC-40; mouse monoclonal; Santa Cruz), anti-β-tubulin (480011; mouse monoclonal; Thermo Fisher Scientific), anti-Dyn2 (ab3457; rabbit polyclonal; Abcam), M2 anti-FLAG (F3165; mouse monoclonal; Sigma-Aldrich), anti-FLAG (F7425; rabbit polyclonal; Sigma-Aldrich), and anti-HA (ab18181; mouse monoclonal; Abcam). Secondary antibodies purchased from Jackson ImmunoResearch Laboratories, including HRP-coupled secondary antibodies, were used for Western blots, and fluorescently labeled secondary antibodies were used for immunostaining. For STED imaging, Abberior Star 580 and Abberior Star Red secondary antibodies were purchased from Abberior Instruments.
For soluble ligand stimulation, Human IgG Fc fragment (Jackson ImmunoResearch Laboratories) or mouse ephrinB1-Fc fusion protein (R&D Systems) was incubated with goat anti-human Fc at a ratio of 5:1 for 30 min (Zimmer et al., 2003 (link)). Cells were incubated with the clustered proteins at a final concentration of 2 µg/ml for 30 min at 37°C.
Dynamin inhibitor Dyngo-4a (ab120689; Abcam) was diluted in DMSO.
+ Open protocol
+ Expand
8

Quantification of IgMRF and IgMRF-α2,6-SIA

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELISA plates were coated with human IgG Fc fragment (Jackson ImmunoResearch Inc.) at 10 μg/mL for IgMRF detection. 29 , 30 Plasma (1:1000 dilution) was added and followed by an HRP-conjugated goat anti-human IgM antibody (Jackson ImmunoResearch Inc.) for IgMRF measurement (designated as plasma IgMRF). Alternatively, an SNA (Sambucus nigra)-HRP solution (EY Laboratories, Inc.) was coated on the plates for measurement of the α2,6-SIA content of IgM (designated as the IgMRF-α2,6-SIA). 30 Human IgGRF and its α2,6-SIA content were detected with rabbit IgG Fc fragment (Jackson ImmunoResearch Inc.) by a similar method.
+ Open protocol
+ Expand
9

Characterization of SP141 and FcRn Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
The small molecule MDM2 inhibitor SP141 was synthesized and characterized as described in our previous studies [12 (link), 14 (link)]. The Mal-PEG-PCL copolymers (6 KDa) were purchased from Advanced Polymer Materials (Montreal, Canada). Human IgG Fc fragments were sourced from Jackson ImmunoResearch Laboratories (West Grove, PA, USA). 2-Iminothiolane hydrochloride was obtained from Sigma (St Louis, MO, USA). DilC18(5) oil (1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine perchlorate) was purchased from Thermo Scientific (Rockford, IL, USA). Fetal bovine serum was obtained from Atlanta Biologicals (Lawrenceville, GA, USA). The penicillin/streptomycin was bought from Corning (Manassas, VA, USA). The antibodies against human p53 (DO-1; 1:2000) and FcRn (H-4; 1:1000) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The antibodies against human MDM2 (Ab-2; 1:500) and p21 (Ab-1; 1:1000) were bought from EMD Chemicals (Gibbstown, NJ, USA). The goat antimouse IgG (H+L) and goat anti-rabbit IgG (H+L) antibodies were obtained from Bio-Rad (Hercules, CA, USA).
+ Open protocol
+ Expand
10

DENV2 E Protein Antibody Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human monoclonal antibodies (#753 C6 and #751 A2) against the DENV2 E protein were a kind gift of J. Mongkolsapaya and G. Screaton (Imperial College, UK). Human IgG Fc-fragments were used as control (Jackson immunoResearch, USA). Antibodies for the phenotyping of the macrophages, and corresponding isotypes, were obtained through an unrestricted grant (Immunotools, DE).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!